Have a feature idea you'd love to see implemented?
Let us know!
TNDM Tandem Diabetes Care Inc
Price (delayed)
$30.74
Market cap
$2.02B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.93
Enterprise value
$2.45B
Tandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.
Highlights
Tandem Diabetes Care's EPS has increased by 40% YoY and by 8% from the previous quarter
The net income has increased by 39% YoY and by 7% from the previous quarter
Tandem Diabetes Care's quick ratio has decreased by 30% YoY and by 2.2% from the previous quarter
The company's equity fell by 24% YoY
Key stats
What are the main financial stats of TNDM
Market
Valuations
Earnings
Shares outstanding
65.68M
Market cap
$2.02B
Enterprise value
$2.45B
Price to earnings (P/E)
N/A
Price to book (P/B)
8.47
Price to sales (P/S)
2.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.86
Revenue
$854.35M
EBIT
-$115.84M
EBITDA
-$99.45M
Free cash flow
-$15.07M
Per share
Balance sheet
Liquidity
EPS
-$1.93
Free cash flow per share
-$0.23
Book value per share
$3.63
Revenue per share
$13.04
TBVPS
$14.61
Total assets
$957.73M
Total liabilities
$720.02M
Debt
$475.95M
Equity
$237.71M
Working capital
$493.55M
Debt to equity
2
Current ratio
2.9
Quick ratio
2.24
Net debt/EBITDA
-4.29
Margins
Efficiency
Dividend
EBITDA margin
-11.6%
Gross margin
49.8%
Net margin
-14.8%
Operating margin
-15.6%
Return on assets
-13.4%
Return on equity
-49.3%
Return on invested capital
-10.2%
Return on capital employed
-16.6%
Return on sales
-13.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TNDM stock price
How has the Tandem Diabetes Care stock price performed over time
Intraday
1.96%
1 week
7.52%
1 month
-9.88%
1 year
66.97%
YTD
3.92%
QTD
-27.52%
Financial performance
How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$854.35M
Gross profit
$425.41M
Operating income
-$133.61M
Net income
-$126.78M
Gross margin
49.8%
Net margin
-14.8%
The net margin has increased by 45% YoY and by 13% from the previous quarter
The operating margin has grown by 44% YoY and by 11% from the previous quarter
The net income has increased by 39% YoY and by 7% from the previous quarter
The operating income rose by 38% YoY and by 3.9% QoQ
Growth
What is Tandem Diabetes Care's growth rate over time
Valuation
What is Tandem Diabetes Care stock price valuation
P/E
N/A
P/B
8.47
P/S
2.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.86
Tandem Diabetes Care's EPS has increased by 40% YoY and by 8% from the previous quarter
TNDM's price to book (P/B) is 37% less than its 5-year quarterly average of 13.4 and 12% less than its last 4 quarters average of 9.6
The company's equity fell by 24% YoY
The P/S is 68% lower than the 5-year quarterly average of 7.4 and 21% lower than the last 4 quarters average of 3.0
TNDM's revenue is up by 11% year-on-year and by 7% since the previous quarter
Efficiency
How efficient is Tandem Diabetes Care business performance
Tandem Diabetes Care's ROS has increased by 46% YoY and by 11% from the previous quarter
The return on invested capital has increased by 43% year-on-year and by 6% since the previous quarter
The return on assets has increased by 37% year-on-year and by 8% since the previous quarter
TNDM's ROE is up by 16% YoY
Dividends
What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TNDM.
Financial health
How did Tandem Diabetes Care financials performed over time
The total assets is 33% greater than the total liabilities
Tandem Diabetes Care's quick ratio has decreased by 30% YoY and by 2.2% from the previous quarter
TNDM's current ratio is down by 28% year-on-year and by 4.9% since the previous quarter
The debt is 100% more than the equity
The company's debt to equity has surged by 50% YoY
The company's equity fell by 24% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.